887 related articles for article (PubMed ID: 17310221)
1. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.
Mensink M; Hesselink MK; Russell AP; Schaart G; Sels JP; Schrauwen P
Int J Obes (Lond); 2007 Aug; 31(8):1302-10. PubMed ID: 17310221
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.
Zorzano A; Hernández-Alvarez MI; Palacín M; Mingrone G
Biochim Biophys Acta; 2010; 1797(6-7):1028-33. PubMed ID: 20175989
[TBL] [Abstract][Full Text] [Related]
3. Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment.
Schrauwen P; Mensink M; Schaart G; Moonen-Kornips E; Sels JP; Blaak EE; Russell AP; Hesselink MK
J Clin Endocrinol Metab; 2006 Apr; 91(4):1520-5. PubMed ID: 16384852
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes.
Wessels B; Ciapaite J; van den Broek NM; Houten SM; Nicolay K; Prompers JJ
Diabetes Obes Metab; 2015 Jan; 17(1):52-60. PubMed ID: 25200673
[TBL] [Abstract][Full Text] [Related]
5. PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein.
Holloway GP; Perry CG; Thrush AB; Heigenhauser GJ; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1060-9. PubMed ID: 18349111
[TBL] [Abstract][Full Text] [Related]
6. Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals.
Wijngaarden MA; van der Zon GC; van Dijk KW; Pijl H; Guigas B
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E1012-21. PubMed ID: 23512807
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
Hoeks J; Hesselink MK; Russell AP; Mensink M; Saris WH; Mensink RP; Schrauwen P
Diabetologia; 2006 Oct; 49(10):2419-26. PubMed ID: 16896940
[TBL] [Abstract][Full Text] [Related]
8. The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function.
Schrauwen-Hinderling VB; Mensink M; Hesselink MK; Sels JP; Kooi ME; Schrauwen P
J Clin Endocrinol Metab; 2008 Jul; 93(7):2917-21. PubMed ID: 18460571
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.
Ruschke K; Fishbein L; Dietrich A; Klöting N; Tönjes A; Oberbach A; Fasshauer M; Jenkner J; Schön MR; Stumvoll M; Blüher M; Mantzoros CS
Eur J Endocrinol; 2010 Mar; 162(3):515-23. PubMed ID: 19966034
[TBL] [Abstract][Full Text] [Related]
10. Human skeletal muscle fibre type variations correlate with PPAR alpha, PPAR delta and PGC-1 alpha mRNA.
Krämer DK; Ahlsén M; Norrbom J; Jansson E; Hjeltnes N; Gustafsson T; Krook A
Acta Physiol (Oxf); 2006; 188(3-4):207-16. PubMed ID: 17054660
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals.
Codner E; Loviscach M; Ciaraldi TP; Rehman N; Carter L; Mudaliar S; Henry RR
Metabolism; 2001 Jul; 50(7):830-4. PubMed ID: 11436190
[TBL] [Abstract][Full Text] [Related]
13. FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
Bravard A; Lefai E; Meugnier E; Pesenti S; Disse E; Vouillarmet J; Peretti N; Rabasa-Lhoret R; Laville M; Vidal H; Rieusset J
Diabetes; 2011 Jan; 60(1):258-68. PubMed ID: 20943749
[TBL] [Abstract][Full Text] [Related]
14. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA
Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes.
Holmström MH; Iglesias-Gutierrez E; Zierath JR; Garcia-Roves PM
Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E731-9. PubMed ID: 22252943
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
[TBL] [Abstract][Full Text] [Related]
17. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.
Hernández-Alvarez MI; Thabit H; Burns N; Shah S; Brema I; Hatunic M; Finucane F; Liesa M; Chiellini C; Naon D; Zorzano A; Nolan JJ
Diabetes Care; 2010 Mar; 33(3):645-51. PubMed ID: 20032281
[TBL] [Abstract][Full Text] [Related]
18. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.
Loviscach M; Rehman N; Carter L; Mudaliar S; Mohadeen P; Ciaraldi TP; Veerkamp JH; Henry RR
Diabetologia; 2000 Mar; 43(3):304-11. PubMed ID: 10768091
[TBL] [Abstract][Full Text] [Related]
19. Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle.
Franko A; von Kleist-Retzow JC; Böse M; Sanchez-Lasheras C; Brodesser S; Krut O; Kunz WS; Wiedermann D; Hoehn M; Stöhr O; Moll L; Freude S; Krone W; Schubert M; Wiesner RJ
J Mol Med (Berl); 2012 Oct; 90(10):1145-60. PubMed ID: 22411022
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses.
Juurinen L; Kotronen A; Granér M; Yki-Järvinen H
J Clin Endocrinol Metab; 2008 Jan; 93(1):118-24. PubMed ID: 17956948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
